Cargando…

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma

Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. In this study, we clarified the clinical significance of CDKN2B antisense RNA 1 (CDKN2B-AS) gene, and its effects on paclitaxel sensitivity in EC. Firstly, CDKN2B-AS gene was highly expressed in EC tissues and ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Chao, Ao, Cheng N., Cheong, Chi C., Meng, Lirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361746/ https://www.ncbi.nlm.nih.gov/pubmed/30761271 http://dx.doi.org/10.3389/fonc.2019.00027

Ejemplares similares

Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma
por: Xie, Dalong, et al.
Publicado: (2018)

Long Non-coding Wilms Tumor 1 Antisense RNA in the Development and Progression of Malignant Tumors
por: Zhang, Ye, et al.
Publicado: (2020)

Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter
por: Ou, Minghui, et al.
Publicado: (2020)

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
por: Dong, Peixin, et al.
Publicado: (2022)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
por: Setijono, Stephanie Rebecca, et al.
Publicado: (2018)

Oncogenic circular RNA circ_0007534 contributes to paclitaxel resistance in endometrial cancer by sponging miR-625 and promoting ZEB2 expression
por: Yi, Hanjie, et al.
Publicado: (2022)

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
por: Liu, Ying, et al.
Publicado: (2022)

Are Antisense Long Non-Coding RNA Related to COVID-19?
por: Badr, Eman A E, et al.
Publicado: (2022)

The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma
por: Gu, Chunyan, et al.
Publicado: (2022)

Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial–mesenchymal transition (EMT) pathway
por: Qi, Fujian, et al.
Publicado: (2022)

Natural Antisense Transcripts and Long Non-Coding RNA in Neurospora crassa
por: Arthanari, Yamini, et al.
Publicado: (2014)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

PVT1 Long Non-coding RNA in Gastrointestinal Cancer
por: Martínez-Barriocanal, Águeda, et al.
Publicado: (2020)

Role of Long Non-Coding RNA LINC00641 in Cancer
por: Han, Xue, et al.
Publicado: (2022)

Long Noncoding RNA UCA1 Is Related to Autophagy and Apoptosis in Endometrial Stromal Cells
por: Jiang, Lili, et al.
Publicado: (2021)

Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5
por: Li, Siwei, et al.
Publicado: (2019)

Long non-coding RNA muskelin 1 antisense RNA as a potential therapeutic target in hepatocellular carcinoma treatment
por: Chen, Xijun, et al.
Publicado: (2022)

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
por: Huang, Kebing, et al.
Publicado: (2021)

Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase 59 pathway
por: Hu, Ke-qi, et al.
Publicado: (2022)

Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer
por: Xue, Jingyan, et al.
Publicado: (2021)

Variation of Long Non-Coding RNA And mRNA Profiles in Breast Cancer Cells With Influences of Adipocytes
por: Cao, Xin-Hui, et al.
Publicado: (2021)

Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
por: Li, Meng-Yuan, et al.
Publicado: (2019)

New Sights Into Long Non-Coding RNA LINC01133 in Cancer
por: Jiang, Shengnan, et al.
Publicado: (2022)

Long non-coding RNA DHRS4 antisense RNA 1 inhibits ectopic endometrial cell proliferation, migration, and invasion in endometriosis by regulating microRNA-139-5p expression
por: Cui, Xuan, et al.
Publicado: (2022)

Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma
por: Liu, Yanping, et al.
Publicado: (2022)

HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion
por: Ros, Gloria, et al.
Publicado: (2020)

Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin
por: Liu, Yang, et al.
Publicado: (2021)

Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
por: Xu, Meng, et al.
Publicado: (2020)

An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes
por: Zimta, Alina-Andreea, et al.
Publicado: (2020)

Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia
por: Ye, Yongqin, et al.
Publicado: (2022)

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
por: Fujiwara, Kazuko, et al.
Publicado: (2011)

Association of Myocardial Infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 Polymorphism in Slovenian Subjects with Type 2 Diabetes Mellitus
por: Tibaut, Miha, et al.
Publicado: (2022)

Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma
por: Pan, Qi, et al.
Publicado: (2022)

Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2020)

Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers
por: Jin, Shi-Jia, et al.
Publicado: (2019)

Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors
por: Lin, Guohong, et al.
Publicado: (2022)

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
por: Zhou, Xuehao, et al.
Publicado: (2022)

Psorachromene Suppresses Oral Squamous Cell Carcinoma Progression by Inhibiting Long Non-coding RNA GAS5 Mediated Epithelial-Mesenchymal Transition
por: Wang, Tong-Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ku5p3nvpomccipgl3rqgku1h5